Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01297660
Other study ID # KEK-2010-0207/01
Secondary ID
Status Completed
Phase N/A
First received February 16, 2011
Last updated December 15, 2016
Start date January 2010
Est. completion date September 2010

Study information

Verified date December 2016
Source Balgrist University Hospital
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Observational

Clinical Trial Summary

Most patients with spinal cord injury suffer from bladder dysfunction which may - especially in the long-term - impair renal function. Improved treatment during the last decades improved life expectancy and quality of life. This study evaluates the bladder function in the long-term after spinal cord injury.


Description:

Bladder dysfunction is a common consequence of spinal cord injury and depends on the completeness and the level of the lesion. Patients with suprasacral injury usually suffer from neurogenic detrusor overactivity mostly combined with detrusor sphincter dyssynergia. Without adequate treatment, this adverse combination puts the upper urinary tract at risk due to high intravesical pressure often causing vesico-ureteral reflux. Based on improved therapeutic options in the last decades, life expectancy and quality of life constantly increased in spinal cord injury patients. The investigators aim to evaluate the bladder function in the long-term after spinal cord injury.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date September 2010
Est. primary completion date September 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Spinal cord injury for at least 5 years

- Neurogenic lower urinary tract dysfunction

- Written informed consent

Exclusion Criteria:

- Lower urinary tract dysfunction due to other causes than spinal cord injury

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Other:
Video-urodynamic examination


Locations

Country Name City State
Switzerland Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital Zürich

Sponsors (1)

Lead Sponsor Collaborator
Balgrist University Hospital

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Urodynamic evaluation Max. cystometric capacity, compliance, detrusor leak point pressure 5 years after SCI, yearly thereafter (participants are followed until death) No
Secondary secondary complications recurrent tract infection, deterioration of the upper urinary tract 5 years after SCI, yearly thereafter (participants are followed until death) No
Secondary imaging of the upper urinary tract videocystography, ultrasound 5 years after SCI, yearly thereafter (participants are followed until death) No
See also
  Status Clinical Trial Phase
Completed NCT01530620 - Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity Phase 3